{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:13:51Z","timestamp":1769836431439,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep05640","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T09:01:32Z","timestamp":1404982892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The role of TMPRSS2:ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian patients"],"prefix":"10.1038","volume":"4","author":[{"given":"Fl\u00e1via C.","family":"Eguchi","sequence":"first","affiliation":[]},{"given":"Eliney F.","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Cristovam Scapulatempo","family":"Neto","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Cleyton","family":"Zanardo-Oliveira","sequence":"additional","affiliation":[]},{"given":"Sebasti\u00e3o R.","family":"Taboga","sequence":"additional","affiliation":[]},{"given":"Silvana G. P.","family":"Campos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,7,10]]},"reference":[{"key":"BFsrep05640_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10\u201329 (2012).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep05640_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J Clin 63, 11\u201330 (2013).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep05640_CR3","unstructured":"INCA. Edn. First. (ed. CEDC. ) (Rio de Janeiro - RJ; 2011)."},{"key":"BFsrep05640_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644\u2013648 (2005).","journal-title":"Science"},{"key":"BFsrep05640_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/pcan.2009.28","volume":"13","author":"K Mwamukonda","year":"2010","unstructured":"Mwamukonda, K. et al. Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status. Prostate Cancer Prostatic Dis 13, 47\u201351 (2010).","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"BFsrep05640_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1593\/neo.06283","volume":"8","author":"M Yoshimoto","year":"2006","unstructured":"Yoshimoto, M. et al. Three-color FISH analysis of TMPRSS2\/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 8, 465\u2013469 (2006).","journal-title":"Neoplasia"},{"key":"BFsrep05640_CR7","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.1158\/0008-5472.CAN-06-1482","volume":"66","author":"S Perner","year":"2006","unstructured":"Perner, S. et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 66, 8337\u20138341 (2006).","journal-title":"Cancer Res"},{"key":"BFsrep05640_CR8","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.urology.2009.01.087","volume":"74","author":"B Lu","year":"2009","unstructured":"Lu, B. et al. Detection of TMPRSS2-ERG Fusion Gene Expression in Prostate Cancer Specimens by a Novel Assay Using Branched DNA. Urology 74, 1156\u20131161 (2009).","journal-title":"Urology"},{"key":"BFsrep05640_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/modpathol.3800903","volume":"20","author":"JJ Tu","year":"2007","unstructured":"Tu, J. J. et al. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues. Mod Pathol 20, 921\u2013928 (2007).","journal-title":"Mod Pathol"},{"key":"BFsrep05640_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1593\/neo.10726","volume":"12","author":"K Park","year":"2010","unstructured":"Park, K. et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia 12, 590\u2013598 (2010).","journal-title":"Neoplasia"},{"key":"BFsrep05640_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/pcan.2011.67","volume":"15","author":"M Braun","year":"2012","unstructured":"Braun, M. et al. ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies. Prostate Cancer Prostatic Dis 15, 165\u2013169 (2012).","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"BFsrep05640_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00428-011-1128-4","volume":"459","author":"SM Falzarano","year":"2011","unstructured":"Falzarano, S. M. et al. ERG gene rearrangement status in prostate cancer detected by immunohistochemistry. Virchows Arch 459, 441\u2013447 (2011).","journal-title":"Virchows Arch"},{"key":"BFsrep05640_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","volume":"27","author":"Q Wang","year":"2007","unstructured":"Wang, Q. et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27, 380\u2013392 (2007).","journal-title":"Mol Cell"},{"key":"BFsrep05640_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.bjc.6603924","volume":"97","author":"M Yoshimoto","year":"2007","unstructured":"Yoshimoto, M. et al. FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome. Br J Cancer 97, 678\u2013685 (2007).","journal-title":"Br J Cancer"},{"key":"BFsrep05640_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"BFsrep05640_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/gcc.20939","volume":"51","author":"M Yoshimoto","year":"2012","unstructured":"Yoshimoto, M. et al. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications. Genes Chromosomes Cancer 51, 149\u2013160 (2012).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFsrep05640_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/ng.371","volume":"41","author":"JC King","year":"2009","unstructured":"King, J. C. et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet 41, 524\u2013526 (2009).","journal-title":"Nat Genet"},{"key":"BFsrep05640_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D'Amico","year":"1998","unstructured":"D'Amico, A. V. et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280, 969\u2013974 (1998).","journal-title":"JAMA"},{"key":"BFsrep05640_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","volume":"452","author":"C Pinheiro","year":"2008","unstructured":"Pinheiro, C. et al. Increased expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas. Virchows Archiv: an international journal of pathology 452, 139\u2013146 (2008).","journal-title":"Virchows Archiv: an international journal of pathology"},{"key":"BFsrep05640_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10863-012-9408-5","volume":"44","author":"AT de Oliveira","year":"2012","unstructured":"de Oliveira, A. T. et al. Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). Journal of bioenergetics and biomembranes 44, 171\u2013178 (2012).","journal-title":"Journal of bioenergetics and biomembranes"},{"key":"BFsrep05640_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/modpathol.3800769","volume":"20","author":"R Mehra","year":"2007","unstructured":"Mehra, R. et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol 20, 538\u2013544 (2007).","journal-title":"Mod Pathol"},{"key":"BFsrep05640_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/modpathol.2008.96","volume":"21","author":"M Yoshimoto","year":"2008","unstructured":"Yoshimoto, M. et al. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol 21, 1451\u20131460 (2008).","journal-title":"Mod Pathol"},{"key":"BFsrep05640_CR23","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/PAS.0b013e31821e8761","volume":"35","author":"A Chaux","year":"2011","unstructured":"Chaux, A. et al. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 35, 1014\u20131020 (2011).","journal-title":"Am J Surg Pathol"},{"key":"BFsrep05640_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4161\/cbt.6.1.3489","volume":"6","author":"RK Nam","year":"2007","unstructured":"Nam, R. K. et al. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 6, 40\u201345 (2007).","journal-title":"Cancer Biol Ther"},{"key":"BFsrep05640_CR25","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1038\/sj.onc.1210237","volume":"26","author":"F Demichelis","year":"2007","unstructured":"Demichelis, F. et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 26, 4596\u20134599 (2007).","journal-title":"Oncogene"},{"key":"BFsrep05640_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1158\/0008-5472.CAN-08-2467","volume":"69","author":"A Gopalan","year":"2009","unstructured":"Gopalan, A. et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res 69, 1400\u20131406 (2009).","journal-title":"Cancer Res"},{"key":"BFsrep05640_CR27","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1158\/1078-0432.CCR-09-2505","volume":"16","author":"KA Leinonen","year":"2010","unstructured":"Leinonen, K. A. et al. Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer. Clin Cancer Res 16, 2845\u20132851 (2010).","journal-title":"Clin Cancer Res"},{"key":"BFsrep05640_CR28","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.juro.2009.12.096","volume":"183","author":"J Rubio-Briones","year":"2010","unstructured":"Rubio-Briones, J. et al. Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy. J Urol 183, 2054\u20132061 (2010).","journal-title":"J Urol"},{"key":"BFsrep05640_CR29","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/modpathol.2010.149","volume":"23","author":"Y Miyagi","year":"2010","unstructured":"Miyagi, Y. et al. ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples. Mod Pathol 23, 1492\u20131498 (2010).","journal-title":"Mod Pathol"},{"key":"BFsrep05640_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/modpathol.2011.176","volume":"25","author":"AM Hoogland","year":"2012","unstructured":"Hoogland, A. M. et al. ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer. Mod Pathol 25, 471\u2013479 (2012).","journal-title":"Mod Pathol"},{"key":"BFsrep05640_CR31","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/1055-9965.EPI-12-0042","volume":"21","author":"A Pettersson","year":"2012","unstructured":"Pettersson, A. et al. The TMPRSS2:ERG rearrangement, ERG expression and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev 21, 1497\u20131509 (2012).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep05640_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2013.4","volume":"16","author":"G Schaefer","year":"2013","unstructured":"Schaefer, G. et al. Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. Prostate Cancer Prostatic Dis 16, 132\u2013138 (2013).","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"BFsrep05640_CR33","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1038\/onc.2008.183","volume":"27","author":"C Sun","year":"2008","unstructured":"Sun, C. et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene 27, 5348\u20135353 (2008).","journal-title":"Oncogene"},{"key":"BFsrep05640_CR34","doi-asserted-by":"publisher","first-page":"e21650","DOI":"10.1371\/journal.pone.0021650","volume":"6","author":"O Leshem","year":"2011","unstructured":"Leshem, O. et al. TMPRSS2\/ERG promotes epithelial to mesenchymal transition through the ZEB1\/ZEB2 axis in a prostate cancer model. PLoS One 6, e21650 (2011).","journal-title":"PLoS One"},{"key":"BFsrep05640_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","volume":"17","author":"J Yu","year":"2010","unstructured":"Yu, J. et al. An integrated network of androgen receptor, polycomb and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17, 443\u2013454 (2010).","journal-title":"Cancer Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep05640","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05640.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05640.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T08:05:10Z","timestamp":1672992310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep05640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep05640"],"URL":"https:\/\/doi.org\/10.1038\/srep05640","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,10]]},"assertion":[{"value":"12 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5640"}}